These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38049937)

  • 21. Impact of Morbid Obesity on Liver Transplant Candidacy and Outcomes: National and Regional Trends.
    Kaur N; Emamaullee J; Lian T; Lo M; Ender P; Kahn J; Sher L
    Transplantation; 2021 May; 105(5):1052-1060. PubMed ID: 33741845
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation.
    Raza MH; Kwon Y; Kobierski P; Misra AC; Lim A; Goldbeck C; Etesami K; Kohli R; Emamaullee J
    Liver Transpl; 2023 Feb; 29(2):134-144. PubMed ID: 35876731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.
    Kim WR; Mannalithara A; Heimbach JK; Kamath PS; Asrani SK; Biggins SW; Wood NL; Gentry SE; Kwong AJ
    Gastroenterology; 2021 Dec; 161(6):1887-1895.e4. PubMed ID: 34481845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Excess waitlist mortality among candidates for multivisceral liver-intestine transplant in acuity circle allocation.
    Kwong AJ; Schnellinger E; Foutz J; Cafarella M; Nagai S; Biggins SW; Pomposelli J; Trotter J
    Am J Transplant; 2024 Jun; 24(6):1080-1086. PubMed ID: 38408641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The impact of surging transplantation of alcohol-associated liver disease on transplantation for HCC and other indications.
    Ayyala-Somayajula D; Dodge JL; Zhou K; Terrault NA; Yuan L
    Hepatol Commun; 2024 Jul; 8(7):. PubMed ID: 38967588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients From Appalachia Have Reduced Access to Liver Transplantation After Wait-Listing.
    Beal EW; Tumin D; Sobotka L; Tobias JD; Hayes D; Pawlik TM; Washburn K; Mumtaz K; Conteh L; Black SM
    Prog Transplant; 2018 Dec; 28(4):305-313. PubMed ID: 30205758
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Black Patients Have Unequal Access to Listing for Liver Transplantation in the United States.
    Rosenblatt R; Wahid N; Halazun KJ; Kaplan A; Jesudian A; Lucero C; Lee J; Dove L; Fox A; Verna E; Samstein B; Fortune BE; Brown RS
    Hepatology; 2021 Sep; 74(3):1523-1532. PubMed ID: 33779992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The race to liver transplantation: a comparison of patients with and without hepatocellular carcinoma from listing to post-transplantation.
    Patel MS; Kohn R; Kratz JR; Shah JA; Markmann JF; Vagefi PA
    J Am Coll Surg; 2015 Jun; 220(6):1001-7. PubMed ID: 25868408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variation in access to the liver transplant waiting list in the United States.
    Mathur AK; Ashby VB; Fuller DS; Zhang M; Merion RM; Leichtman A; Kalbfleisch J
    Transplantation; 2014 Jul; 98(1):94-9. PubMed ID: 24646768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates.
    Kardashian A; Ge J; McCulloch CE; Kappus MR; Dunn MA; Duarte-Rojo A; Volk ML; Rahimi RS; Verna EC; Ganger DR; Ladner D; Dodge JL; Boyarsky B; McAdams-DeMarco M; Segev DL; Lai JC
    Hepatology; 2021 Mar; 73(3):1132-1139. PubMed ID: 32491208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aging of Liver Transplant Registrants and Recipients: Trends and Impact on Waitlist Outcomes, Post-Transplantation Outcomes, and Transplant-Related Survival Benefit.
    Su F; Yu L; Berry K; Liou IW; Landis CS; Rayhill SC; Reyes JD; Ioannou GN
    Gastroenterology; 2016 Feb; 150(2):441-53.e6; quiz e16. PubMed ID: 26522262
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Should All Status 1A Patients Be Prioritized Over High MELD Patients? Concept of Risk Stratification in Extremely Ill Liver Transplant Recipients.
    Safwan M; Nwagu U; Collins K; Abouljoud M; Nagai S
    Transplantation; 2019 Oct; 103(10):2121-2129. PubMed ID: 30747840
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients with Alcoholic Liver Disease Have Worse Functional Status at Time of Liver Transplant Registration and Greater Waitlist and Post-transplant Mortality Which Is Compounded by Older Age.
    McCabe P; Galoosian A; Wong RJ
    Dig Dis Sci; 2020 May; 65(5):1501-1511. PubMed ID: 31642005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Travel distance and social vulnerability index: Impact on liver-related mortality among patients with end-stage liver disease.
    Yang J; Endo Y; Moazzam Z; Lima HA; Woldesenbet S; Alaimo L; Azap L; Shaikh CF; Munir MM; Katayama E; Sasaki K; Pawlik TM
    Clin Transplant; 2023 Sep; 37(9):e15001. PubMed ID: 37126400
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved liver transplant waitlist mortality and lower risk of disease progression among chronic hepatitis C patients awaiting liver transplantation after the introduction of direct-acting antiviral therapies in the United States.
    Young K; Liu B; Bhuket T; Gish RG; Wong RJ
    J Viral Hepat; 2019 Mar; 26(3):350-361. PubMed ID: 30412318
    [TBL] [Abstract][Full Text] [Related]  

  • 36. More severe deficits in functional status associated with higher mortality among adults awaiting liver transplantation.
    McCabe P; Wong RJ
    Clin Transplant; 2018 Sep; 32(9):e13346. PubMed ID: 29979466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. State-Level Variation in Waitlist Mortality and Transplant Outcomes Among Patients Listed for Heart Transplantation in the US From 2011 to 2016.
    Akintoye E; Shin D; Alvarez P; Briasoulis A
    JAMA Netw Open; 2020 Dec; 3(12):e2028459. PubMed ID: 33295970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cumulative Social Disadvantage and All-Cause Mortality in the United States: Findings from a National Study.
    Javed Z; Valero-Elizondo J; Khan SU; Taha MB; Maqsood MH; Mossialos E; Sharma G; Hyder AA; Cainzos-Achirica M; Nasir K
    Popul Health Manag; 2022 Dec; 25(6):789-797. PubMed ID: 36473192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of Liver Offers to Pediatric Candidates on the Transplant Wait List.
    Hsu EK; Shaffer ML; Gao L; Sonnenday C; Volk ML; Bucuvalas J; Lai JC
    Gastroenterology; 2017 Oct; 153(4):988-995. PubMed ID: 28711630
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of the implementation of acuity circle policy on waitlist and post-transplant outcomes of liver re-transplantation.
    Shimada S; Shamaa T; Ivanics T; Miyake K; Kitajima T; Rizzari M; Yoshida A; Abouljoud M; Moonka D; Nagai S
    Clin Transplant; 2023 Jun; 37(6):e14977. PubMed ID: 36951511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.